<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ackermann M</submitter><funding>Swiss National Science Foundation</funding><funding>European Research Council</funding><funding>Deutsche Forschungsgemeinschaft (German Research Foundation)</funding><funding>NHLBI NIH HHS</funding><pagination>3125-3139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8142290</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(11)</volume><pubmed_abstract>SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putativ</pubmed_abstract><journal>Cell death and differentiation</journal><pubmed_title>Patients with COVID-19: in the dark-NETs of neutrophils.</pubmed_title><pmcid>PMC8142290</pmcid><funding_grant_id>R01 HL150392</funding_grant_id><funding_grant_id>CRC1181: C03</funding_grant_id><funding_grant_id>K08 HL131993</funding_grant_id><funding_grant_id>4D Nanoscope</funding_grant_id><funding_grant_id>184816</funding_grant_id><funding_grant_id>310030</funding_grant_id><funding_grant_id>TRR241: B04</funding_grant_id><pubmed_authors>Vitkov L</pubmed_authors><pubmed_authors>Kolaczkowska E</pubmed_authors><pubmed_authors>Rovere-Querini P</pubmed_authors><pubmed_authors>Bilyy R</pubmed_authors><pubmed_authors>Egeblad M</pubmed_authors><pubmed_authors>Stark K</pubmed_authors><pubmed_authors>Sturzl M</pubmed_authors><pubmed_authors>Hohberger B</pubmed_authors><pubmed_authors>Kanthi Y</pubmed_authors><pubmed_authors>Zarbock A</pubmed_authors><pubmed_authors>Schauer C</pubmed_authors><pubmed_authors>Skendros P</pubmed_authors><pubmed_authors>Maueroder C</pubmed_authors><pubmed_authors>Mitroulis I</pubmed_authors><pubmed_authors>Manfredi AA</pubmed_authors><pubmed_authors>Kaplan MJ</pubmed_authors><pubmed_authors>Mahajan A</pubmed_authors><pubmed_authors>Singh J</pubmed_authors><pubmed_authors>Munoz LE</pubmed_authors><pubmed_authors>Knopf J</pubmed_authors><pubmed_authors>Neeli I</pubmed_authors><pubmed_authors>Anders HJ</pubmed_authors><pubmed_authors>Vandenabeele P</pubmed_authors><pubmed_authors>Kubes P</pubmed_authors><pubmed_authors>Ng LG</pubmed_authors><pubmed_authors>Daniel C</pubmed_authors><pubmed_authors>van der Vlag J</pubmed_authors><pubmed_authors>Schett G</pubmed_authors><pubmed_authors>Leppkes M</pubmed_authors><pubmed_authors>Herrmann M</pubmed_authors><pubmed_authors>Narasaraju T</pubmed_authors><pubmed_authors>Yanginlar C</pubmed_authors><pubmed_authors>Hidalgo A</pubmed_authors><pubmed_authors>Yousefi S</pubmed_authors><pubmed_authors>Radic MZ</pubmed_authors><pubmed_authors>Simon HU</pubmed_authors><pubmed_authors>von Kockritz-Blickwede M</pubmed_authors><pubmed_authors>Bowlin GL</pubmed_authors><pubmed_authors>Maugeri N</pubmed_authors><pubmed_authors>Ackermann M</pubmed_authors><pubmed_authors>Ritis K</pubmed_authors><pubmed_authors>Henneck T</pubmed_authors><pubmed_authors>Knight JS</pubmed_authors><pubmed_authors>De Lorenzo R</pubmed_authors><pubmed_authors>Naschberger E</pubmed_authors><pubmed_authors>Hoffmann M</pubmed_authors><pubmed_authors>Schapher M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patients with COVID-19: in the dark-NETs of neutrophils.</name><description>SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putativ</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-07-14T13:27:36.144Z</modification><creation>2022-02-11T12:51:08.078Z</creation></dates><accession>S-EPMC8142290</accession><cross_references><pubmed>34031543</pubmed><doi>10.1038/s41418-021-00805-z</doi></cross_references></HashMap>